TradeLink Capital LLC acquired a new stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 18,600 shares of the financial services provider’s stock, valued at approximately $2,043,000. iShares Nasdaq Biotechnology ETF makes up about 9.8% of TradeLink Capital LLC’s holdings, making the stock its 4th biggest position.

A number of other hedge funds have also recently bought and sold shares of the business. Investment Management of Virginia LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter worth approximately $3,708,000. Mcmillion Capital Management Inc. lifted its position in shares of iShares Nasdaq Biotechnology ETF by 3.6% in the second quarter. Mcmillion Capital Management Inc. now owns 22,804 shares of the financial services provider’s stock worth $2,504,000 after purchasing an additional 787 shares in the last quarter. Gerber Kawasaki Wealth & Investment Management lifted its position in shares of iShares Nasdaq Biotechnology ETF by 6.3% in the second quarter. Gerber Kawasaki Wealth & Investment Management now owns 108,965 shares of the financial services provider’s stock worth $12,061,000 after purchasing an additional 6,487 shares in the last quarter. Florin Court Capital LLP purchased a new stake in shares of iShares Nasdaq Biotechnology ETF in the second quarter worth approximately $242,000. Finally, Sandy Spring Bank lifted its position in shares of iShares Nasdaq Biotechnology ETF by 11.7% in the second quarter. Sandy Spring Bank now owns 31,424 shares of the financial services provider’s stock worth $3,451,000 after purchasing an additional 3,280 shares in the last quarter. 59.52% of the stock is owned by institutional investors.

iShares Nasdaq Biotechnology ETF opened at $116.73 on Friday, according to Marketbeat.com. iShares Nasdaq Biotechnology ETF has a 52-week low of $100.22 and a 52-week high of $120.06.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: Book Value Per Share – BVPS

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.